Medicine and Dentistry
Hepatocellular Carcinoma
100%
Neoplasm
65%
Surgery
63%
Overall Survival
35%
Disease
34%
Hyperthermic Intraperitoneal Chemotherapy
33%
Cytoreductive Surgery
33%
Thyroidectomy
30%
Hepatitis B
30%
Malignant Neoplasm
30%
Hepatitis B Virus
27%
Recurrent Disease
27%
Hepatectomy
26%
Surgery
25%
Carcinomatous Peritonitis
22%
Cholangiocarcinoma
20%
Abdominal Cancer
20%
Fibrosis
19%
Systematic Review
19%
Metastatic Carcinoma
18%
Cancer
17%
Neoadjuvant Chemotherapy
16%
Thyroid Gland
15%
Hepatic Portal Vein
14%
Pancreas Adenocarcinoma
14%
Pancreas Cancer
14%
Liver Fibrosis
14%
Diseases
12%
Intraperitoneal Chemotherapy
12%
Liver Cirrhosis
11%
Yttrium 90
11%
Chemoradiotherapy
11%
Primary Hyperparathyroidism
11%
Radioembolization
11%
Embolization
11%
Adenocarcinoma
11%
Neuromonitoring
11%
Thyroid Nodule
11%
Multivariate Analysis
10%
Lobectomy
10%
Circular DNA
10%
Surgeon
10%
Carcinoma
9%
Gallbladder Cancer
9%
Meta-Analysis
9%
Parathyroid
9%
Primary Tumor
9%
Thyroid Cancer
8%
Adjuvant Therapy
8%
Chronic Hepatitis B
8%
Recurrence Free Survival
8%
Liver Disease
8%
Microsphere
8%
Chemotherapy
8%
Hyperparathyroidism
7%
Liver Transplantation
7%
Tumor Progression
7%
Neck
7%
Hepatitis Virus
7%
Diagnosis
7%
Adverse Event
7%
Pancreaticoduodenectomy
7%
Papillary Thyroid Cancer
7%
Local Therapy
7%
Quality Improvement
7%
Hepatobiliary Cancer
7%
Computer Assisted Tomography
7%
Transplantation
6%
Disease Exacerbation
6%
Lymph Node
6%
Nonalcoholic Fatty Liver
6%
Thyroid Surgery
6%
Neoadjuvant Therapy
6%
Cancer Staging
6%
Isotopes of Calcium
6%
Surgical Oncology
5%
Decision Making
5%
Neck Dissection
5%
Peritoneum Cancer
5%
Lymph Node Metastasis
5%
Gastroesophageal Junction
5%
Next Generation Sequencing
5%
Retroperitoneal Lymph Node Dissection
5%
Hazard Ratio
5%
Hypercalcaemia
5%
Response Evaluation Criteria in Solid Tumors
5%
Kaplan Meier Method
5%
Survival Rate
5%
Child-Pugh Score
5%
Platelet
5%
Keyphrases
Hepatocellular Carcinoma
89%
Resection
51%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
37%
Cytoreductive Surgery
33%
Liver
32%
Tumor
30%
Hepatitis B
26%
Overall Survival
25%
Peritoneal Carcinomatosis
22%
Surgical Resection
22%
Liver Resection
18%
Thyroidectomy
17%
Neoadjuvant Chemotherapy
16%
Pancreatic Cancer
14%
Metastasis
14%
Pancreatic Ductal Adenocarcinoma
14%
Surgical Management
14%
Liver Fibrosis
13%
Non-neoplastic
13%
Gallbladder Cancer
13%
Hepatitis B Virus
12%
Fibrosis
11%
Gastric Cancer
11%
Neoadjuvant
11%
Primary Hyperparathyroidism (pHPT)
11%
Radioembolization
11%
Tumor Size
11%
HBV-related Hepatocellular Carcinoma
11%
Portal Vein Embolization
11%
Liver Transplantation
11%
Cirrhosis
11%
Single Institution
11%
Oncological Outcomes
10%
Malignancy
10%
Ishak Stage
10%
Multivariate Analysis
10%
Covalently Closed Circular DNA
9%
5-year Survival
9%
Outcome Prediction
9%
Intrahepatic Cholangiocarcinoma (iCCA)
8%
Adjuvant Therapy
8%
Primary Tumor
8%
Neoadjuvant Chemoradiotherapy (nCRT)
8%
Mount Sinai
8%
Meta-analysis
8%
Alpha-fetoprotein
8%
Hepatitis C Virus Infection
8%
Liver Tissue
7%
Disease Progression
7%
Hepatitis C Virus
7%
Confidence Interval
7%
Tumor Progression
7%
Graves' Disease
7%
Non-associated
7%
Viral Hepatitis
7%
Indeterminate Thyroid Nodules
7%
ThyroSeq
7%
Post-thyroidectomy
7%
Preoperative Localization
7%
Benchmark Values
7%
Papillary Thyroid Carcinoma
7%
Hepatobiliary Cancer
7%
Yttrium-90
7%
Chronic Hepatitis B
7%
Single-center Experience
7%
Neuromonitoring
7%
Phase II Trial
7%
Huge Hepatocellular Carcinoma
7%
Western Perspective
7%
Liver Reserve Function
7%
Human Liver
7%
Reserve Estimation
7%
Local Treatment
7%
Expert Center
7%
Pancreaticoduodenectomy
7%
Resectable Gastric Cancer
7%
Ultrasound
7%
Pathologic
7%
HBV-HCC
7%
Lobectomy
7%
Partial Response
7%
Recurrence-free Survival
7%
Hepatocellular Carcinoma Patients
7%
Microvascular Invasion
6%
Poor Outcome
6%
Thyroid Cells
6%
Thyroid Surgery
6%
Patient Selection
6%
National Cancer Database
6%
Median Overall Survival
6%
Nonalcoholic Steatohepatitis
6%
Surgeons
6%
Neoadjuvant Therapy
6%
Recurrence Risk
6%
Median Survival
6%
Systematic Meta-analysis
6%
Hypercalcemia
6%
Glands
6%
Tumor Recurrence
6%
Lung
5%